Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer
NCT01378598
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
OTHER:
Nursing Educational Intervention
Sponsor
Dana-Farber Cancer Institute